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Numerous carriers and encapsulation techniques have been evaluated for prepara-
tion of microcapsules with sustained-release properties. However, literature survey re-
vealed that most of the drugs used were relatively water-insoluble. While water insoluble
compounds have inherent sustained-release properties when incorporated in a polymer
matrix and are relatively easy to encapsulate, preparation of sustained release microcap-
sules of water-soluble pharmaceuticals pose a great challenge (3). Among the various
methods developed for formulation of microspheres, the solvent evaporation method has
gained much attention due to its ease of fabrication without compromising the activity
of the drug (4).
Ropinirole hydrochloride is a selective non-ergoline dopamine D2 receptor agonist
indicated for use in treating Parkinson’s disease. It is a potent drug with a dose of 2 mg
to be administered 3–4 times daily. It is a highly water-soluble drug (133 mg mL–1) with
plasma half-life of 6 h (5). It is also soluble in dichloromethane (DCM), methanol, ethanol,
etc. Results from efficacy and safety trials showed that adding extended release ropinirole
to the patients on levodopa therapy reduced the amount of "off" time experienced by the
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patient. The on-off phenomenon associated with the Parkinson’s patient may also be due to
fluctuation of the drug plasma concentration. Microsphere based drug delivery system
of ropinirole hydrochloride will thus offer an accurate and more reliable drug release
over a prolonged period under such circumstances. Parkinsonism therapy involves variable
dosing of ropinirole hydrochloride and thus a number of extended release tablets having
different strengths (2, 4, 6 and 8 mg) have been developed as per requirement. This leads
to increased developmental cost, which would be avoided in the case of microsphere
based drug delivery as the dose could be titrated as per need and requirement.
The emulsion-solvent evaporation technique has been used successfully in the prepa-
ration of microspheres made from several biocompatible polymers such as polymethacry-
late, albumin, waxes, polylactic-co-glycolic acid (PLGA), chitosan, etc. (6–8). Oil-in-water
emulsions are preferred for preparation of microspheres of water-insoluble drugs over
water-in-oil emulsions due to the simplicity of the process. In the present investigation, a
polar organic solvent in oil system was used for preparation of ropinirole hydrochloride
microspheres. Ethylcellulose, a water-insoluble polymer, in combination with polyethy-
lene glycol 6000, a plasticizer and release modifier, were used as encapsulation materials.
Besides developing a microsphere-based controlled drug delivery system of ropini-
role hydrochloride, another important objective was to determine the influence of process
variables such as selection of internal and external phases, surfactant, stirring speed, etc.,
on microsphere characteristics, such as drug incorporation, shape and in vitro drug re-
lease rate. Extended-release tablet of ropinirole hydrochloride based on the matrix type
system may lead to dose dumping and gastric irritation associated with matrix polymer.
EXPERIMENTAL
Materials
Ropinirole hydrochloride was obtained as a gift sample from Lupin Research Park,
India. Ethylcellulose (EC) was obtained as a gift sample from Colorcon Asia Ltd., India.
All other chemicals and reagents used were of analytical grade.
Formulation optimization
Based on preliminary trials, a 2-factor 3-level full factorial design was employed
to design controlled release microspheres of ropinirole hydrochloride. This design was
suitable for exploring quadratic response surfaces and constructing second-order poly-
nomial models. The two independent formulation variables analyzed during the study
were the ratio of drug/ethylcellulose (X1) and the portion of polyethylene glycol (PEG)
in ethylcellulose (X2) (Table I). All other independent variables were kept constant
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Table I. Coded levels of polymer and plasticizer
Variables levels Low (–1) Medium (0) High (+1)
Drug/ethylcellulose (X1) 1:1 1:2 1:3
PEG portion in EC (%) (X2) 0 5 10
throughout the process. Dependent variables investigated were the encapsulation ef-
ficiency (EE) (Y1) and the time taken for 100 % of the drug to be released (Y2) (Table
II) (9).
Methods
Weighed amounts of ropinirole hydrochloride, ethylcellulose and PEG 6000 were
dissolved in ethanol in three different beakers separately using a magnetic stirrer (Remi,
2MLH, India). PEG solution was then added to ethylcellulose solution and mixed for
15 minutes. To the resulting solution of polymers, drug solution was added and mixed.
This solution was then added in a thin stream to a beaker containing a mixture of 90 mL
light liquid paraffin, 10 mL n-heptane and 2 % (V/V) Span 80 in liquid paraffin under
stirring at 500–700 rpm with a mechanical stirrer. Stirring was continued for 2 h at room
temperature until ethanol evaporated completely and microspheres were formed. The
formed microspheres were initially filtered through a nylon cloth and then finally filtered
through Whatman no. 1 filter paper. The microspheres were washed 4–5 times with a to-
tal volume of petroleum ether of 50 mL. The product was then dried at room tempera-
ture for 24 hours. All batches were prepared in triplicate. This method was developed on
the basis of practical observations, which are discussed in the later part by carrying out
certain modifications to the existing methods (10, 11).
Effect of process parameters
Viscosity of external phase. – In the preparation of microspheres, heavy liquid paraffin
was initially employed as an external phase. Then light liquid paraffin alone and then
along with n-heptane were tried. n-Heptane was incorporated as a viscosity reducing
agent and its effect on formation of microspheres was studied.
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Table II. Composition of ropinirole microspheres prepared as per 32 factorial design
Formulation
code
Variable levels in coded form





F1 –1 +1 37.5 ± 0.8 18.6 ± 0.5 2.0 ± 0.3
F2 –1 0 38.2 ± 0.9 19.2 ± 0.5 3.0 ± 0.3
F3 –1 –1 41.7 ± 0.7 20.9 ± 0.9 4.0 ± 0.6
F4 0 +1 56.9 ± 0.7 14.2 ± 0.7 6.0 ± 0.5
F5 0 0 58.8 ± 1.0 14.7 ± 0.2 7.0 ± 0.5
F6 0 –1 60.3 ± 0.9 20.1 ± 0.4 9.0 ± 0.4
F7 +1 +1 77.0 ± 0.7 19.3 ± 0.4 12.1 ± 0.3
F8 +1 0 78.7 ± 1.0 19.7 ± 0.3 19.1 ± 0.2
F9 +1 –1 79.4 ± 0.8 19.8 ± 1.0 32.5 ± 0.5
a Mean ± SD, n = 3.
Encapsulation efficiency (EE) is the percentage of encapsulated drug.
Loading efficiency (DL) is the concentration of the drug in the formulation.
Organic solvent as internal phase. – In the present study, dichloromethane, methanol,
ethanol and combination of these solvents were employed as internal phases. Effect of
internal solvent on formation of microspheres was studied by analyzing the shape, sur-
face morphology and release profile.
Surfactant. – Selection of the dispersing agent was based on solubility criteria in the
external phase. Literature survey revealed the use of Span 80 and Tween 80 for prepara-
tion of microspheres (12, 13).
Stirring speed. – Microspheres of ropinirole hydrochloride were prepared at different
stirring speeds and the effect on encapsulation efficiency, size of microspheres and drug
release from microspheres was observed.
Characterization of microspheres
Product yield. – The yield of microspheres of various batches was calculated using
the mass of the final product after drying with respect to the initial total mass of the
drug and polymer used for preparation of microspheres.
Encapsulation efficiency and loading efficiency. – About 11.4 mg of ropinirole hydrochlo-
ride equivalent to 10 mg ropinirole base was weighed accurately and transferred to a
50-mL volumetric flask to which 20 mL methanol was added and sonicated for 15 min.
Final volume was made with mobile phase (methanol/0.05 mol L–1 ammonium acetate,
pH 7.0; 80:20, V/V). The formed solution was filtered through Whatman filter paper.
One mL of this solution was withdrawn and further diluted up to 10 mLwith the mobile
phase. An aliquot was used for the determination of drug concentration by HPLC
(Perkin Elmer series 200, USA) using a UV detector kept at 250 nm (14). Concentration
of the drug in stock solution was calculated using the calibration curve.
Surface morphology. – Shape and surface morphological examination of drug micro-
spheres was done by scanning electron microscopy (SEM). Dried samples were coated
with platinum using an auto fine coater (JFC 1600, Jeol, Japan). These samples were ob-
served under different magnifications with an analytical scanning electron microscope
(Jeol-JSM 6360A).
Differential scanning calorimetry. – The possibility of any interaction between ropini-
role hydrochloride and polymer was studied by differential scanning calorimetry (DSC),
which was performed using a Shimadzu-thermal analyzer DT 40, Japan. Thermograms
were obtained at a scanning rate of 10 °C min–1 conducted over a temperature range of
30–300 °C in a liquid nitrogen environment (flow rate 10 mL min–1).
Micromeretic properties of microspheres. – Angles of repose of different formulations
were calculated according to the fixed funnel standing method (15). Bulk density and
tapped density were measured in a 10-mL graduated cylinder using a bulk density ap-
paratus (15). Carr’s compressibility index of microspheres was computed (15).
Particle size and particle size distribution. – The particle size distribution of different
batches of microspheres was determined by optical microscopy. The projected diameter
of microspheres was determined using an image analyzer (Labomed, India) that consisted
of an optical microscope linked to a computer and digital camera. The digitalized images
captured were analyzed with image analyzing software (Digipro version 2, Labomed,
India).
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In vitro drug release and kinetics. – In vitro release of ropinirole from the microspheres
was performed in a modified USP type I dissolution apparatus, in which the basket was
covered with nylon cloth (0.15 mm), at a speed of 50 rpm (15, 16). The dissolution me-
dium was 500 mL of citrate buffer (pH 4.0) at 37.0 ± 0.5 oC. The aliquots of samples were
analyzed by HPLC at 250 nm. Cumulative percentage drug release was calculated and
the data was then fitted into various mathematical models. There are several models of
the drug dissolution profiles where the amount of the drug dissolved from the system is
a function of time (t). Quantitative interpretation of the values obtained in the dissolu-
tion is facilitated by the usage of mathematical equations (17). Models with major appli-
ance and best describing drug release phenomena are the Higuchi model, zero-order
model, Weibull model and Korsmeyer-Peppas model. The criteria for chooseing the
''best model'' to study drug dissolution/release phenomena are based on the use of the R
value; the ''best'' model would be the one with the highest adjusted R (19).
Regression analysis. – Targeted response parameters were statistically analyzed by ap-
plying one-way ANOVA at 0.05 level in the Design-Expert® 7.1.6 demo version software
(Stat-Ease Inc., USA). Individual response parameters were evaluated using the F-test
and quadratic models of the form given below were generated for each response parame-
ter using multiple linear regression analysis:
Y = b0 + b1X1 + b2X2 + b3X1X2 + b4X2 + b5X22
where Y is the level of the measured response, b0 is the intercept, b1 to b5 are the regres-
sion coefficients, X1 and X2 stand for the main effects, X1X2 is the interaction between
the main effects, X12 and X22 are the quadratic terms of the independent variables that
were used to simulate the curvature of the designed sample space. A backward elimina-
tion procedure was adopted to fit the data to the quadratic model. The quadratic models
generated from the regression analysis were used to construct 3-dimensional graphs, in
which the response parameter Y was represented by a curved surface as a function of X.
The effects of independent variables on the response parameters were visualized from
the contour plots (18, 19).
RESULTS AND DISCUSSION
Process parameters. – Only heavy liquid paraffin was initially used as a dispersion
medium to generate the emulsion; however, serious agglomeration was observed during
the process. The high viscosity (110–230 mPa s) of heavy liquid paraffin may have forced
the droplets of organic polymer solution to coalesce, or may have prevented the droplets
from separating following collision during the stirring procedure. Light liquid paraffin
has comparatively low viscosity (25–80 mPa s) and so it was tried instead of heavy liquid
paraffin. This resulted in sticking of the formed microspheres to the walls of the beaker.
To overcome this problem, part of liquid paraffin was replaced by n-heptane. It was ob-
served that addition of n-heptane reduced the viscosity of the dispersion medium and the
small viscosity differences between the internal and external phases increased the stabili-
ty of the emulsion system and sticking was prevented. In addition, the specific gravity
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of the internal phase was somewhat lower than that of the oil phase. A reduction in the
specific gravity of the oil phase due to replacement by heptane may have prevented the
emulsion from creaming. A 90:10 ratio of light liquid paraffin to heptane was found to
be satisfactory in preventing agglomeration during the stirring process, which resulted
in increased production yield (Table III) as well as in obtaining perfectly smooth spheri-
cal microspheres (Fig. 1a).
DCM was initially employed as polar internal organic solvent phase for preparation
of microspheres because it is a good solvent for most polymers and drugs. However, it
was observed that the microparticles obtained were not spherical in shape, as shown in
Fig. 1b. To solve this problem, methanol was used along with dichloromethane for prepa-
ration of microspheres. The microspheres prepared using dichloromethane and metha-
nol are shown in Fig. 1c. These microspheres were spherical but lacked smooth texture.
It was observed that the boiling point of internal organic solvents may affect the spheric-
ity and surface smoothness of microspheres. The boiling point of DCM (39.75 °C) is low
and leads to rapid evaporation of DCM, resulting in polymer precipitation. The use of
methanol, which has a comparatively high boiling point (64.7 °C), resulted in spherical
microspheres but lacked surface smoothness. Hence, instead of dichloromethane or meth-
anol, ethanol was used. Ethanol was selected as polar organic solvent because it is a good
solvent for most water-soluble drugs and water-insoluble polymers, and it is non-toxic.
Ethanol also has a high boiling point (78.4 °C) compared to other organic solvents (di-
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Fig. 1. SEM photomicrograph of ropinirole mi-
crospheres prepared with: a) ethanol (85x), b) di-




chloromethane, acetone, methanol, etc.), which prevented immediate polymer precipita-
tion, as well as dispersion of ethanol (internal phase) as droplets in the oily phase, lead-
ing to the formation of a stable emulsion.
The emulsifier Tween 80 is a water-soluble surfactant, which is used when water is
the external phase, while Span is an oil soluble surfactant used for preparation of emul-
sion when the external phase is oil-like mineral oil. In the present investigation, liquid
paraffin was the external phase of the w/o emulsion. The required hydrophilic-lipophilic
balance (HLB) for this case is 4.0. Span 20 has an HLB value of 8.9 while Span 80 has HLB
4.3 and was used as a surfactant in the present study. Span 80 also provided a protective
sheath around organic polymer droplets and prevented the droplets from coalescing.
Both the shape and size distribution of the particles depended heavily on the stir-
ring speed. Rapid rotation of the stirrer (1200–1500 rpm) resulted in smaller particle size
(< 100 µm), with narrower particle size distribution. However, rapid drug release (100 %
after 3 h) was observed from the microspheres prepared at higher speed. This was pre-
sumably due to the small particle size that led to a much larger surface area available for
release and shorter path length for the drug to diffuse through microspheres. Encapsula-
tion efficiency at this speed was also found to be lower, i.e., 35.0 ± 0.6 % than that ob-
tained by stirring speed of 500–700 rpm (F3) which may be due to the increase in effective
surface area that led to drug exposure to the solvent during the washing stage. How-
ever, agglomeration was observed when stirring speed was kept low (100–200 rpm). Fi-
nally, the 500–700 rpm stirring speed was selected for preparation of microspheres, at
which speed encapsulation efficiency was found to be 40.5 ± 0.8 % and particle size was
300–500 µm.
Various channeling agents like HPMC, citric acid, polyvinyl pyrolidine, PEG, etc.,
were screened for the present study. Ethanol was used as an internal phase, so the first
criterion for the channeling agent was that it must be soluble in ethanol and insoluble in
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F1 1.11 ± 0.31 23.7 ± 0.7 11.2 ± 0.9 75.5 ± 1.8
F2 1.11 ± 0.31 21.6 ± 0.4 11.2 ± 0.9 74.9 ± 1.9
F3 1.00 ± 0.22 24.2 ± 0.6 9.9 ± 0.8 76.1 ± 1.2
F4 1.11 ± 0.31 26.7 ± 0.8 11.2 ± 0.9 77.1 ± 1.5
F5 1.11 ± 0.31 22.6 ± 0.3 11.2 ± 0.9 78.1 ± 1.6
F6 1.00 ± 0.22 26.2 ± 0.7 9.9 ± 0.8 77.3 ± 1.5
F7 1.11 ± 0.31 22.7 ± 0.5 11.2 ± 0.9 78.7 ± 1.4
F8 1.11 ± 0.31 23.6 ± 0.9 11.2 ± 0.9 77.3 ± 2.0
F9 1.11 ± 0.31 25.2 ± 0.6 11.2 ± 0.9 77.9 ± 1.1
F3* 1.00 ± 0.22 24.7 ± 0.8 9.9 ± 0.8 68.8 ± 1.6
aMicrospheres prepared without n-heptane in dispersion medium.
external phase, i.e., liquid paraffin. Polyethylene glycol is chemically stable, soluble in
ethanol (95 %) and methanol, but insoluble in fats, fixed oils, and mineral oil. Besides,
PEG has good plasticity and binding properties. Thus due to these favourable properties,
PEG appeared to be an ideal channeling agent and was selected for these microspheres.
Microspheres were washed to remove residual traces of liquid paraffin and the
drug, which could have been adhering on the surface of microspheres. The solvent has
to be selected based on the fact in which polymer is insoluble, but the drug and liquid
paraffin are soluble. Various washing solvents such as water, ether, hexane and petro-
leum ether were used for washing the formed microspheres. Petroleum ether is the sol-
vent in which liquid paraffin and the drug are soluble, while EC is insoluble; so petro-
leum ether was employed for washing formed microspheres.
Characterization of microspheres
The yield of formed microspheres was found in the range of 74 to 78 %, as shown in
Table IV.
Encapsulation of the drug increased from F3 to F9 due to increase in polymer con-
centration in a fixed volume of organic solvent. Highest encapsulation (79.4 ± 0.8 %) was
observed for formulation F9. Encapsulation efficiency of the microspheres prepared with
ethylcellulose alone was higher (F3, F6, F9) than for the microspheres prepared with the
ethylcellulose/PEG combination. This can be attributed to the hydrophilic nature of
PEG, which might have facilitated the diffusion of some of the entrapped drug to the
surrounding medium during formation of the microspheres (Table II).
Surface morphology characteristics were studied using SEM (Figs. 1a–c). SEM indi-
cated that the microspheres prepared with ethanol were perfectly spherical with a smooth
surface (Fig. 1a). The photomicrographs also showed the presence of loose crystals on
the surface of a few microspheres prepared with the combination of dichloromethane
and methanol (Fig. 1c), while the particles made using only DCM were irregular in shape
and were not able to retard drug release even at higher concentration of ethylcellulose
(Fig. 1b).
Drug-polymer interactions were studied by DSC. Fig. 2 depicts the DSC thermo-
grams of ropinirole hydrochloride, physical mixture (ropinirole hydrochloride + ethyl-
cellulose + PEG 400) and ropinirole microspheres. The DSC of ropinirole hydrochloride
exhibited a single sharp endothermic peak at 250 °C corresponding to its melting transi-
370
A. M. Avachat et al.: Sustained release microspheres of ropinirole hydrochloride: Effect of process parameters, Acta Pharm. 61 (2011)
363–376.
Table IV. Dissolution models and kinetics
Formulation
code
Zero-order First-order Higuchi/matrix Korsmeyer-Peppas
R k0 (mg h–1) R k1 (h–1) R kh (mg h–1/2) R kkp (mg h–n) n
F9 0.626 0.0075 0.627 –0.0001 0.963 0.0224 0.980 0.0327 0.3030
F8 0.712 0.0102 0.712 –0.0001 0.984 0.0304 0.998 0.0387 0.3773
F7 0.700 0.0118 0.700 –0.0001 0.980 0.0352 0.995 0.0422 0.4109
k – rate constant, n – diffusion exponent.
tion temperature. A slightly broadened peak was observed in the thermogram of the
physical mixture at the same temperature. This may be due to the fact that the presence of
ethylcellulose in the physical mixture depresses the melting point of ropinirole hydrochlo-
ride and broadens its melting point endotherm. The peak of the drug did not appear in
the thermogram of drug microspheres. This may indicate that the drug was uniformly
dispersed at the molecular level in the microspheres (20).
Angle of repose, bulk density and Carr’s index were determined to predict flow pro-
perties. The prepared microspheres exhibited good flow properties (Table III).
The mean diameter of microspheres was found to be 400 µm. Particle size mainly
depends on the stirring speed, which was kept constant throughout the process. Particle
size distribution of the optimized batch is shown in Fig. 3.
In vitro drug release profiles and kinetics
Drug release decreased as the portion of polymer. Formulations F1 to F3 (drug/EC
1:1) show higher drug release as compared to other formulations, F4 to F6 (drug/EC 1:2),
as well as to F7 to F9 (drug/EC 1:3). Formulations containing PEG (F7 and F8) showed
more rapid drug release than those containing only ethylcellulose (F3, F6, F9). Formula-
tion F7 (10 % of PEG) showed more rapid release than F9 (no PEG). As the concentration
of PEG increases, the pores on surfaces also increase, which leads to faster drug release
(21). Formulation F7 with high levels of both 1:3 drug/ethylcellulose and 10 % of PEG
was able to control drug release for 12 h (Fig. 4).
When fitted into various mathematical models, the best linearity was found in the
Korsmeyer-Peppas plot (R = 0.995), indicating that the release of the drug from micro-
spheres follows the Korsmeyer-Peppas model (17) (Table IV).
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Fig. 2. DSC thermogram of: a) ropinirole hydrochloride microspheres, b) physical mixture of ropini-
role hydrochloride + ethylcellulose + PEG400, c) ropinirole hydrochloride.
The n value in the Korsmeyer-Peppas model describes the drug release mechanism.
It is known that when n < 0.5, Fickian diffusion is observed and the release rate is inde-
pendent of t, while 0.5 < n < 1.0 indicates anomalous (non-Fickian) transport and when
n = 1 the release is zero-order (17). Here n was found to be less than 0.5, which may indi-
cate that the release of ropinirole from ethylcellulose matrix follows Fickian diffusion.
Regression analysis
The surface quadratic model generated for encapsulation efficiency was found to be
significant, with an F-value of 197.56 (p < 0.0006) and R2 value of 0.9970. The polynomial
equation for the response variable encapsulation efficiency was:
EE (%) = 59.67 + 19.64X1 – 1.06X2 – 0.41X1X2 + 0.074X12 – 1.54X22
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Fig. 3. Particle size distribution of optimized formulation F7. Mean ± SD, n = 3.
Fig. 4. Dissolution profile of various ropinirole hydrochloride microsphere formulations. Mean ± SD,
n = 6.
The model indicated that both factors, i.e., drug/EC ratio and % of PEG exerted in-
dependently a significant influence on the encapsulation efficiency. The 3-D plot (Fig.
5a) shows that the encapsulation efficiency increased from 37.5 ± 0.8 % (F1) to 79.4 ± 0.8 %
(F9) at lower and higher levels of ethylcellulose, respectively. In contrast, encapsulation
efficiency declined from 79.4 ± 0.8 % in F9 to 77.0 ± 0.7 % in F7 at high ethylcellulose load
as PEG level increased from low to high, which could be due to the hydrophilic nature
of PEG. Similar results were obtained with intermediate and low levels of ethylcellulose
with respect to PEG amounts. A linear relationship was observed between the two vari-
ables of encapsulation efficiency, i.e., drug/EC ratio and % of PEG, which is clearly visi-
ble from the corresponding contour plots, which suggest that encapsulation efficiency
could be enhanced using low PEG levels at high ethylcellulose levels. From the equa-
tion, it is clearly visible that the positive value is obtained for factor X1, which shows a
positive effect on encapsulation. Negative values were obtained for X2 and X1X2, which
show a negative effect on encapsulation leading to a decrease in encapsulation efficiency
(Fig. 5a). A similar kind of relationship was observed for loading efficiency (DL). Namely,
for a constant drug/EC ratio, there was a corresponding increase in loading efficiency,
with the decrease in PEG concentration. The change was significant when the drug/EC
ratio was low, but as the drug/EC ratio increased, the change was minimal (Table II).
The mathematical model generated for time taken for 100 % drug release (T100) was
found to be significant with F-value of 19.87 (p < 0.0166) and R2 value of 0.9707. The
polynomial equation for the response variable time for 100 % drug release was:
T100 = 6.72 + 8.02X1 – 3.90X2 – 4.18X1X2 + 4.08X12 + 1.33X22
The mathematical models generated indicated that both the ethylcellulose loads and
PEG levels exerted independently a significant influence on T100. The positive influence
of the levels of both these factors on T100 is clearly demonstrated by the response sur-
face plots (Fig. 5b). Slower drug release with increased ethylcellulose loads was due to
better encapsulation of the drug in the polymer matrix, which resulted in high T100 val-
ues. The 3-D plots also show that the T100 reduces from 32.5 ± 0.5 to 12.1 ± 0.3 h at higher
ethylcellulose loads as PEG content increased from lower to higher levels. Similarly for
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Fig. 5. Response surface 3D plots for: a) encapsulation efficiency, b) T100.
a) b)
lower ethylcellulose loads, T100 reduced from 4.0 ± 0.6 to 2.0 ± 0.3 h when the PEG con-
centration increased from lower to higher levels. This can be attributed to the hydro-
philic and leaching property of PEG, which increased the magnitude of the voids and
consequently the channels from the microsphere surface, resulting in the formation of a
heavily structured, microporous matrix. The equation suggests that factor X1 has a posi-
tive effect on T100. As the level of X1 increases, T100 also increases. X2 and X1X2 have a
negative effect on the T100 leading to decrement in T100 as the level of X2 increases.
The results of ANOVA, as shown in Table V, indicate that the quadratic model was
significant for all response parameters investigated. The multiple linear regression analy-
sis revealed that both the formulation variables analyzed had a significant influence on
all response parameters. The results obtained indicate that optimum amounts of ethyl-
cellulose and PEG are essential to produce microspheres with desirable encapsulation
and release characteristics.
CONCLUSIONS
Microspheres containing ropinirole hydrochloride were successfully prepared by the
emulsion solvent evaporation method. The factorial data suggests that a high ratio of
drug to ethylcellulose and high level of PEG (F7) play a significant role in controlling the
release of ropinirole hydrochloride with the desired release profile from its microspheres.
Process parameters like the viscosity of the external phase, properties of the internal
phase, surfactant, washing solvent and stirring speed had a major influence on the charac-
teristics of microspheres and can be optimized to obtain the desirable properties built in
the microcapsules. This also suggests that microspheres can be a good alternative to ma-
trix-based tablets in Parkinsonism therapy, which offers dose flexibility, prolongs GI re-
sidence and can prevent dose dumping.
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Table V. Summary of ANOVA for the response parameters of microspheres prepared as
per 32 factorial design
Source D. f. Sum square Mean square F-value Probability
EE (%) R2 = 0.9970
Model 5 2326.17 465.23 197.56 0.0006
X1 1 2313.93 2313.93 982.58 <0.0001
X2 1 6.79 6.79 2.88 0.1882
X1X2 1 0.67 0.67 0.29 0.6301
T100 (h) R2 = 0.9707
Model 5 583.97 116.79 19.87 0.0166
X1 1 385.84 385.84 65.66 0.0039
X2 1 91.41 91.41 15.55 0.0291
X1X2 1 69.95 69.95 11.90 0.0409
Sum square – Sum of squares of the difference between the individual value and the mean of the values
R2 – coefficient of determination.
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S A @ E T A K
Mikrosfere ropinirol hidroklorida za polagano osloba|anje:
Utjecaj procesnih parametara
AMELIA M. AVACHAT, PRALHAD N. BORNARE i RAKESH R. DASH
Mikrosfere ropinirol hidroklorida, ljekovite tvari vrlo dobro topljive u vodi, priprav-
ljene su metodom isparavanja otapala, koriste}i etilcelulozu i PEG te 32 potpuno faktori-
jalno dizajniranje. Mikrosfere su pripravljene na sljede}i na~in: otopina ljekovite tvari u
polarnom organskom otapalu emulgirana je s teku}im parafinom kao vanjskom uljnom
fazom. Ispitivan je utjecaj razli~itih procesnih parametara poput viskoznosti vanjske faze,
vrste interne faze i povr{inski aktivne tvari te brzine mije{anja. Za pripravljene mikro-
sfere odre|eno je iskori{tenje, u~inkovitost inkapsuliranja i veli~ina ~estica. Isprobavani
su razli~iti odnosi ljekovite tvari i etilceluloze te koncentracija PEG-a. In vitro pokusi su
pokazali da je osloba|anje ljekovite tvari kontrolirano tijekom 12 h.
Klju~ne rije~i: ropinirol hidroklorid, mikrosfere, etilceluloza, isparavanje otapala, faktorijalno dizaj-
niranje
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